TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
BioNexus Gene Lab Corp ( (BGLC) ) has issued an update.
BioNexus Gene Lab Corp faces potential delisting from Nasdaq due to non-compliance with the minimum bid price rule, but has requested a hearing to present a compliance plan. Simultaneously, the company strengthens its leadership by appointing Ms. Jook Yuen Low as an independent director, bringing substantial expertise in corporate governance and legal compliance, and promoting Mr. Su-Leng Tan Lee to President, aiming to align with strategic goals during this critical compliance phase.
Find detailed analytics on BGLC stock on TipRanks’ Stock Analysis page.